上海
上海，2026年10月8日 – 药明康德今日宣布，公司连续第三年获得国际可持续发展评估权威机构EcoVadis授予的“金牌”。这一认可充分体现了公司对可持续发展的坚定承诺。
EcoVadis是全球供应链领域领先的可持续发展评级机构，其评级围绕环境、劳工与人权、商业道德和可持续采购四大主题，对企业的21项可持续发展绩效指标进行评估。在EcoVadis的评估体系中，奖牌依据企业的全球百分位排名授予，其中“金牌”授予全球排名前5%的受评企业。
“我们很荣幸再次荣获EcoVadis‘金牌’，这充分体现了药明康德在整个价值链的可持续发展中，积极践行负责任的商业实践，并取得卓越的绩效表现。”药明康德联席首席执行官、可持续发展委员会主席杨青博士表示，“药明康德始终致力于推动全球医药健康领域的可持续发展，帮助客户加速更多突破性疗法早日上市，早日实现‘让天下没有难做的药，难治的病’的伟大愿景。”
作为创新的赋能者、客户信赖的合作伙伴以及全球健康产业的贡献者，药明康德和大多数客户一样，积极践行对可持续发展的承诺。截至目前，公司已获得多家国际权威可持续发展评级机构的认可，包括MSCI ESG “AAA”级；CDP气候变化、水安全及供应商参与“A”级榜单；入选道琼斯领先全球指数和S&P Global《可持续发展年鉴》；入选富时罗素社会责任指数系列；ISS ESG企业评级“Prime”表彰。
此外，药明康德不断深化可持续发展承诺，公司温室气体减排近期目标成功通过了SBTi审核认证；公司已加入联合国全球契约组织（UNGC），承诺支持全球契约十项原则，同时加入制药供应链倡议（PSCI），成为PSCI供应商合作伙伴。
关于药明康德
药明康德（股票代码：603259.SH/2359.HK）是全球医药及生命科学行业值得信赖的合作伙伴和重要贡献者，致力于通过提供一体化、端到端的新药研发和生产服务，推动全球医药健康创新。公司在亚洲、欧洲、北美等地均设有运营基地，依托独特的“CRDMO”业务模式，不断降低研发门槛，助力客户提升研发效率，为患者带来突破性的治疗方案。目前，公司的赋能平台正承载着来自全球30多个国家的合作伙伴的研发创新项目，致力于将更多新药、好药带给全球病患，早日实现“让天下没有难做的药，难治的病”的愿景。更多信息，请访问公司网站：www.wuxiapptec.com
WuXi AppTec Earns EcoVadis Gold Medal for Third Consecutive Year, Ranking Among Global Top 5% for Sustainability
SHANGHAI, October 7, 2026 – WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), has received a Gold medal from EcoVadis for the third consecutive year, reflecting the Company's consistent commitment to sustainability.
EcoVadis is a leading sustainability rating agency for global supply chains. Its ratings assess companies based on 21 sustainability criteria across four main themes: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement. Under the EcoVadis assessment framework, medals are awarded based on a company’s percentile ranking, with Gold reserved for the top 5% of companies globally.
“We are honored to once again receive the EcoVadis Gold Medal. This recognition reflects the significant progress we have made in implementing sustainability and responsible business practices throughout our entire value chain,” said Dr. Steve Yang, Co-CEO of WuXi AppTec and Chairman of WuXi AppTec’s Sustainability Committee. “We will continue to support the sustainable development of the global pharmaceutical industry, enabling our customers to bring more life-changing medicines to patients around the world and advancing our vision that 'every drug can be made, and every disease can be treated.'”
As an enabler of innovation, a trusted partner, and a contributor to the global pharmaceutical and life sciences industry, WuXi AppTec integrates sustainability throughout its operations in alignment with the values of its customers and partners. The Company holds some of the highest ratings awarded by leading global agencies, including an “AAA” rating from MSCI; an “A List” CDP ranking in Climate Change, Water Security, and Supplier Engagement; selection for Dow Jones Best-in-Class World Index and S&P Global Sustainability Yearbook; a position in the FTSE4Good Index Series; and a “Prime” award from ISS ESG Corporate Rating.
Furthering its sustainability commitments, WuXi AppTec's near-term greenhouse gas emissions reduction targets have been validated by the Science Based Targets initiative (SBTi). The Company is also a participant in the United Nations Global Compact (UNGC), supporting its ten principles, and serves as a supplier partner to the Pharmaceutical Supply Chain Initiative (PSCI).
About WuXi AppTec
WuXi AppTec is a trusted partner and contributor to the pharmaceutical and life sciences industries, providing R&D and manufacturing services that help advance healthcare innovation. With operations across Asia, Europe, and North America, we offer integrated, end-to-end services through our unique CRDMO (Contract Research, Development, and Manufacturing Organization) platform. We are privileged to work alongside partners across 30+ countries, supporting their efforts to bring breakthrough treatments to patients. Guided by our vision that every drug can be made and every disease can be treated, we are committed to advancing breakthroughs for patients—one collaboration at a time. Learn more at www.wuxiapptec.com.
免责声明：本文仅作信息交流之目的，文中观点不代表药明康德立场，亦不代表药明康德支持或反对文中观点。本文也不是治疗方案推荐。如需获得治疗方案指导，请前往正规医院就诊。
版权说明：欢迎个人转发至朋友圈，谢绝媒体或机构未经授权以任何形式转载至其他平台。转载授权请在「药明康德」微信公众号回复“转载”，获取转载须知。
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
